Canada markets closed

  • S&P/TSX
    16,198.97
    -47.75(-0.29%)

  • S&P 500
    3,319.47
    -37.54(-1.12%)

  • DOW
    27,657.42
    -244.56(-0.88%)

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1510-0.0090 (-5.63%)
At close: 3:26PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
21,078
20,319
1,948
937.654
253.321
Cost of Revenue
34,808
34,788
5,048
1,223
603.267
Gross Profit
-13,730
-14,469
-3,099
-285.517
-349.946
Operating Expenses
Research Development
3,784
4,279
801.351
207.5
301.526
Selling General and Administrative
27,763
30,409
32,825
8,321
2,173
Total Operating Expenses
34,031
36,543
34,245
8,811
2,591
Operating Income or Loss
-47,761
-51,012
-37,344
-9,097
-2,941
Interest Expense
-
-
218.6
0
39.678
Total Other Income/Expenses Net
-65,665
-62,947
5,370
93.608
-
Income Before Tax
-114,235
-113,005
-31,007
-8,842
-2,941
Income Tax Expense
-
-1,099
-23.611
0
0
Income from Continuing Operations
-113,137
-111,907
-30,983
-8,842
-2,941
Net Income
-112,431
-111,141
-30,577
-8,732
-2,941
Net Income available to common shareholders
-112,431
-111,141
-30,577
-8,732
-2,941
Basic EPS
-
-0.75
-0.22
-0.10
-0.05
Diluted EPS
-
-0.75
-0.22
-0.10
-0.05
Basic Average Shares
-
147,961
141,443
88,448
54,265
Diluted Average Shares
-
147,961
141,443
88,448
54,265
EBITDA
-
-44,582
-27,341
-8,559
-2,824